GlassScriptPhysician profile
Pedro M Caram
NPI 1740266014
$6,634.49
in general payments reported to CMS, 2019-2025
11 companies · $977 in 2025
The $977 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $284 · 2021: $369 · 2022: $3,656 · 2023: $527 · 2024: $364 · 2025: $977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,867.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,167.14 | 2019-2025 | Proclaim, Eterna, Infinity |
| Choice Spine, LLC | $444.55 | 2024-2025 | Stratofuse, Blackhawk Cervical Spacer System, Veo Lateral Interbody Fusion System |
| Nuvasive, INC. | $206.24 | 2022 | |
| Inspire Medical Systems, INC. | $165.24 | 2022 | |
| Medtronic USA, INC. | $163.62 | 2019 | |
| Medtronic, INC. | $137.15 | 2021-2022 | |
| Centinel Spine, LLC | $130.62 | 2019-2022 | |
| Medicrea USA, Corp. | $130.17 | 2019 | |
| Osseus Fusion Systems, LLC | $45.00 | 2023 | |
| Mckesson Medical-Surgical, INC. | $25.00 | 2022 | |
| Spine Wave, INC. | $19.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Caram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.